Participation in the Congress is open to clinicians and researchers throughout the world interested in the exchange of information on drug therapy in HIV infection. Only fully paid pre-registered delegates will be allowed to take part in the congress; on-site registration will not be possible.
You can view the current programme schedule here. 
